Aufa, S., & Ismy, J. (2026). Sequential Gemcitabine and Docetaxel Versus BCG for High-Risk Non-Muscle-Invasive Bladder Cancer. Indonesian Journal of Global Health Research, 8(6), 89–98. https://doi.org/10.37287/ijghr.v8i6.2572